Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neuroblastoma 11Ganglioneuroblastoma 5Wilms Tumor 4Rhabdoid Tumor 4Medulloblastoma 4Rhabdomyosarcoma 3Central Nervous System Neoplasms 3Neuroectodermal Tumors, Primitive, Peripheral 2Neoplasms, Germ Cell and Embryonal 2Neoplasms 2Lymphoma 2Carcinoma, Renal Cell 2Carcinoma, Hepatocellular 2Brain Neoplasms 2Astrocytoma 2Testicular Neoplasms 1Supratentorial Neoplasms 1Sarcoma, Ewing 1Sarcoma 1Retinoblastoma 1Recurrence 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pinealoma 1Pheochromocytoma 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Optic Nerve Glioma 1Neurofibrosarcoma 1Neuroectodermal Tumors, Primitive 1Neoplasms, Nerve Tissue 1

Interventions

Bevacizumab 3contrast agent BR1 2Oncolytic Virotherapy 2vorasidenib 1pembrolizumab 1keyhole-limpet hemocyanin 1interferon gamma-1b 1Vaccines 1Temozolomide 1Stem Cell Transplantation 1Microbubbles 1Interleukin-12 1Interferon-gamma 1Immunotherapy 1Biopsy 1Antibodies, Monoclonal 1AZD 6244 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms, Nerve Tissue × Stem Cell Transplantation × CNS × Clear all
NCT02745756 2017-08-30

A Combined Cell Therapy Approach to the Treatment of Neuroblastoma

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Withdrawn
CNS

Neoplasms, Neoplasms, Nerve Tissue, Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡